HRSA's HIV/AIDS Bureau (HAB) contracted with the George Washington University to conduct a series of studies regarding various aspects of HIV medications funding through the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, including the Title II-funded AIDS Drug Assistance Program and Title I-funded AIDS Pharmaceutical Assistance Programs. The goal of the studies was to inform HAB regarding (1) opportunities to promote more efficient use of scarce resources for HIV-related medications and (2) policy options that might ensure equitable access to life-saving therapies for low-income people living with HIV (PLWH). The three key issues addressed and the related study questions are shown in Table 1 on page 3. This report summarizes the methods, limitations, major findings, and recommendations of these studies. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of HRSA.
Levi, J., Hidalgo, J., Palen, J., Parrish, E. B., Williams, K., & Lara, A. S. (2003). Maximizing access to medications through efficient use of CARE Act resources. Rockville, MD: U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau.